PhaseV is introducing a groundbreaking webinar series aimed at reshaping clinical trial design and execution through artificial intelligence and data science.
The first session, titled “Transforming Clinical Development: Leveraging AI, Real-World Evidence, and Predictive Analytics”, is set to take place on March 6, from 1:00-2:00 PM EST. The webinar will bring together leading industry experts to discuss AI’s role in optimizing patient selection, improving recruitment strategies, and enhancing trial success rates.
Key Speakers and Discussion Topics
This expert panel will feature:
- Etai Jacob, PhD – Senior Director, Head of Applied Data Science and AI, Oncology R&D, AstraZeneca
- Jacqueline Law, PhD – Vice President, Corporate Development, Flatiron Health
- J. Jack Lee, PhD, DDS – Professor of Biostatistics, MD Anderson Cancer Center
Moderated by Brad Carlin, PhD, Senior Director of Data Science and Statistics at PhaseV, the session will cover:
- AI-driven strategies for optimizing patient recruitment and site selection
- Bayesian and adaptive trial designs to enhance clinical trial flexibility
- Utilizing real-world data to strengthen trial design and decision-making
- How predictive modeling can improve trial outcomes and strategic decisions
- Regulatory challenges in implementing AI and machine learning in clinical trials
Why AI is Crucial for the Future of Clinical Trials
With the rapid advancement of artificial intelligence, clinical trials are undergoing a significant transformation. AI-powered tools are making it possible to streamline trial processes, reduce costs, and enhance accuracy in patient selection. These improvements lead to faster drug development cycles and more effective treatments for patients.
The implementation of AI in clinical trials aligns with a broader trend of AI integration across industries. As companies adopt AI to drive innovation, ensuring oversight and ethical AI application remains a critical discussion point. Eric Schmidt recently highlighted the risks associated with AI if not properly regulated, emphasizing the importance of responsible AI deployment in sensitive sectors like healthcare.
How to Attend the Webinar
Participants can register for the webinar via this registration link. Following the discussion, an interactive Q&A session will allow attendees to engage directly with the panelists.
“AI and data-driven methodologies are redefining clinical development,” said Raviv Pryluk, PhD, CEO and Co-founder of PhaseV. “By integrating AI-powered patient selection, leveraging real-world evidence, and applying predictive modeling, we can enhance efficiency, improve decision-making, and increase trial success rates.”
Final Thoughts
As AI continues to revolutionize the healthcare sector, PhaseV’s initiative to educate professionals on AI-driven clinical trial optimization is timely and essential. This webinar series will serve as a key platform for industry leaders to discuss challenges, opportunities, and the future of AI in clinical research.
Stay tuned for more sessions in this series as experts unveil new breakthroughs in AI-powered clinical development.
